CompaniesByCap
RCKT
Rocket Pharmaceuticals Inc. (RCKT)
NASDAQ · Healthcare

Rocket Pharmaceuticals Inc. Income Statement 2016–2025

Income StatementBalance SheetCash Flow
Dec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
Revenues
Revenue0000000000
Gross Profit
Profitability
Operating Income-231.7M-273.2M-259.7M-224.3M-167.2M-134.3M-76.2M-71.2M-19.8M-7.6M
EBITDA-222.8M-266.0M-254.8M-220.4M-164.0M-133.2M-75.7M-70.8M
Net Income-223.1M-258.7M-245.6M-221.9M-169.1M-139.7M-77.3M-74.5M-19.6M-7.6M
Per Share Data
EPS (diluted)$-2.01$-2.73$-2.92$-3.26$-2.67$-2.52$-1.58
Shares Outstanding (dil.)111M95M84M68M63M55M49M45M7M7M

Rocket Pharmaceuticals Inc. Income Statement — FAQ

Rocket Pharmaceuticals Inc. (RCKT) income statement over the last 10 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see RCKT's income statement history?

The chart and table above show Rocket Pharmaceuticals Inc.'s income statement by year and by quarter, including the growth rate.